hotspot -WSS

hotspot

author：leisure time 2025-10-01 15:28:43 - browse：12

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Caregivers of transplant patients call for more support, training

WSS

Flash flood warnings continue for parts of Missouri, Illinois

The SUPPORT Act is critical to fighting the opioid crisis

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

With heat waves through August, officials warn of health risks

Paxlovid rebound happens. Why and to whom are still a mystery

New England Journal of Medicine addresses racist history, slavery

Wikipedia

hotspot

knowledge

Sports medicine is finally prioritizing gender equality

Democrats are overperforming in 2023's special elections. Is it a clue for Biden vs. Trump?

After affirmative action ruling, medical educators look to 'holistic review'

GSK to buy asthma

23andMe had bad news about my health. I wish a person had delivered it

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

How one medical school became remarkably diverse

Health and fitness trackers are measuring the wrong things

Virginia high school admissions case could be legal follow

With heat waves through August, officials warn of health risks

Wikipedia

The SUPPORT Act is critical to fighting the opioid crisis

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Feed a cold, starve a fever? Here’s what science says

Caregivers of transplant patients call for more support, training

The nurse manager staffing crisis is hurting patients

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

leisure time

leisure time

entertainment

hotspot